1. Home
  2. SNDX vs BBN Comparison

SNDX vs BBN Comparison

Compare SNDX & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • BBN
  • Stock Information
  • Founded
  • SNDX 2005
  • BBN 1983
  • Country
  • SNDX United States
  • BBN United States
  • Employees
  • SNDX N/A
  • BBN N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • BBN Finance Companies
  • Sector
  • SNDX Health Care
  • BBN Finance
  • Exchange
  • SNDX Nasdaq
  • BBN Nasdaq
  • Market Cap
  • SNDX 1.2B
  • BBN 1.0B
  • IPO Year
  • SNDX 2016
  • BBN N/A
  • Fundamental
  • Price
  • SNDX $13.18
  • BBN $16.59
  • Analyst Decision
  • SNDX Strong Buy
  • BBN
  • Analyst Count
  • SNDX 10
  • BBN 0
  • Target Price
  • SNDX $36.20
  • BBN N/A
  • AVG Volume (30 Days)
  • SNDX 1.8M
  • BBN 231.8K
  • Earning Date
  • SNDX 03-03-2025
  • BBN 01-01-0001
  • Dividend Yield
  • SNDX N/A
  • BBN 6.90%
  • EPS Growth
  • SNDX N/A
  • BBN N/A
  • EPS
  • SNDX N/A
  • BBN N/A
  • Revenue
  • SNDX $23,680,000.00
  • BBN N/A
  • Revenue This Year
  • SNDX $274.86
  • BBN N/A
  • Revenue Next Year
  • SNDX $130.47
  • BBN N/A
  • P/E Ratio
  • SNDX N/A
  • BBN N/A
  • Revenue Growth
  • SNDX N/A
  • BBN N/A
  • 52 Week Low
  • SNDX $12.06
  • BBN $14.33
  • 52 Week High
  • SNDX $25.07
  • BBN $18.36
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 43.83
  • BBN 49.89
  • Support Level
  • SNDX $12.70
  • BBN $16.45
  • Resistance Level
  • SNDX $14.29
  • BBN $16.74
  • Average True Range (ATR)
  • SNDX 0.66
  • BBN 0.11
  • MACD
  • SNDX 0.03
  • BBN -0.01
  • Stochastic Oscillator
  • SNDX 45.32
  • BBN 54.55

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.

Share on Social Networks: